Showing results (1-10 of 303) with videos related to
Sort By:
Pageof 31
Progress in Molecular Biology and Translational Science|November 9, 2019
Future horizons in Alzheimer's disease researchThomas Wisniewski, Eleanor DrummondNeurobiology of Disease|February 7, 2020
APOE-amyloid interaction: Therapeutic targetsThomas Wisniewski, Eleanor DrummondActa Neuropathologica|December 28, 2016
Alzheimer's disease: experimental models and realityEleanor Drummond, Thomas WisniewskiExpert Review of Vaccines|November 19, 2015
Developing therapeutic vaccines against Alzheimer's diseaseThomas Wisniewski, Eleanor DrummondExpert Review of Vaccines|July 15, 2018
Recent advancements toward therapeutic vaccines against Alzheimer's diseaseKrystal Herline, Eleanor Drummond, Thomas WisniewskiMethods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Use of Affinity Purification-Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer's DiseaseGeoffrey Pires, Beatrix Ueberheide, Thomas Wisniewski, et al.Methods in Molecular Biology (Clifton, N.J.)|January 19, 2018
Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream ProteomicsEleanor Drummond, Shruti Nayak, Geoffrey Pires, et al.Journal of Alzheimer'S Disease : JAD|March 23, 2018
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's DiseaseEleanor Drummond, Fernando Goñi, Shan Liu, et al.Nature Communications|July 25, 2023
Compilation of reported protein changes in the brain in Alzheimer's diseaseManor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.Acta Neuropathologica Communications|December 5, 2019
Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathiesGeoffrey Pires, Sacha McElligott, Shiron Drusinsky, et al.Pageof 31